Complimenti.....Sei entrato nel piu' completo Portale sulle Medicine Alternative, Biologico  Naturali e Spirituali - la Guida alla Salute Naturale - Leggi, Studia, Pratica e starai in Perfetta  Salute, senza Farmaci ne' Vaccini


GUIDA  alla  SALUTE con la Natura

"Medicina Alternativa"   per  CORPO  e   SPIRITO
"
Alternative Medicine"
  for  BODY  and SPIRIT
 

 
 


Bibliografia su AIDS e medicine Complementari 
HIV = AIDS ? NO !


Gli sconvolgenti documenti ufficiali, alcuni dei quali totalmente inediti in Italia, che provano la truffa dell'Hiv-Aids.
Fatti a me ben noti, da giornalista investigativo e dati per scontati gia' nel 1983....
Frutto di 3 anni di ricerca intesa e ostacolata di un dottore italiano che, minacciato di morte, è emigrato all'estero. Facciamo girare e diffondiamo il più possibile per favore. Grazie a tutte/i.
http://www.scribd.com/doc/135713547/Hiv-La-Frode-Scientifica-Del-Secolo-documenti-Ufficiali
L'altra storia dell'Aids + Hiv virus inventato

 

BIBLIOGRAFIA
1.  Elion RA, Cohen C. Complementary medicine and HIV Infection. Primary Care. 1997;24:905-919.
2. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States,     1990-1997:  results of a follow-up national survey. JAMA. 1998;280:1569-1575.
3. Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med.1998;158(20):2257-2264.
4.  Ernst E. Complementary AIDS therapies: the good, the bad, and the ugly. Int J STD AIDS. 1997;8:281-285.
5.  Anderson W, O'Connor BB, MacGregor RR, Schwartz JS. Patient use and assessment of conventional and alternative therapies for HIV infection and AIDS. AIDS. 1993;7:561-566.
6.  Ostrow MJ, Cornelisse PGA, Health KV, et al. Determinants of complementary therapy use in HIV-infected  individuals receiving antiretroviral or anti-opportunistic agents.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:115-120.
7.   Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci. 1978;67:1487-1489.
8.  Heptinstall S, Awang DV, Dawson BA, et al. Parthenolide content and bioactivity of feverfew. Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol. 1992;44:391-395.
9.  Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet. 2000;355(9203):547-548.
10. De Maat MMR, Hoetelmans RMW, van Gorp ECM, de Boer A, Beijnen JH. A potential drug interaction between St. John's wort and nevirapine? First International Workshop on Clinical Pharmacology of HIV Therapy; March 30-31, 2000; Noordwijk, The Netherlands. Abstract 2.8.
11.  Dalvi RR. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol Lett.
    1992;60:299-305.
12. Laroche M, Choudhri S, Gallicano K, Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. In: Program and Abstracts of the Canadian Association for HIV Research Seventh Annual Canadian Conference on HIV/AIDS; April 30 - May 3 1998; Quebec City, PQ, Canada. Abstract 471P.
13. Zima T, Kamenkova L, Janebova M, Buchar E, Crkovska J, Tesar V. The effect of silibinin on experimental cyclosporine nephrotoxicity. Ren Fail. 1998;20:471-479.
14. Racz K, Feher J, Csomos G, Varga I, Kiss R, Glaz E. An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells. J Endocrinol. 1990;124:341-345.
15. Leber HW, Knauff S. Influence of silymarin on drug metabolizing enzymes in rat and man.
 
Arzneimittelforschung. 1976;26:1603-1605.
16. Henderson GL, Harkey MR, Gershwin ME, et al. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. 1999;65:PL209-214.
17. 
Kim HJ, Chun YJ, Park JD, et al. Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Med. 1997;63:415-418.
18. Tyler VE. What pharmacists should know about herbal remedies. J Am Pharm Assoc. 1996;NS36:29-37.
19. Natural Medicines Comprehensive database. Stockton, Calif: Therapeutic Research Faculty, 2000.
20. Phillips LG, Nichols MH, King WD. Herbs and HIV: the health food industry's answer. South Med J. 1995;88:911-913.
21.   Snow B. Internet sources of information on alternative medicine. Database. 1998; Aug/Sept:65-73.  

Altra Bilbiografia

1. BLATTNER, W.; GALLO, R. C; and TEMIN, H. M. HIV causes AIDS. Science 241:515­516, 1988.
2. WEBER, J. AIDS and the "guilty" virus. New Scientist, pp. 32­33, May 5, 1988
3. CENTERS FOR DISEASE CONTROL. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36, suppl.: 3S­9S, 1987.
4. LEVINE, A. S. Viruses, immune dysregulation, and oncogenesis: inferences regarding the cause and evolution of AIDS. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, edited by A. E. FRIEDMAN­KIEN and L. J. LAUBSENSTEIN. New York: Masson, 1984.
5. DUESBERG, P. H. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res. 47:1199 ­ 1220, 1987.
6. DUESBERG, P. H. HIV is not the cause of AIDS. Science 241:514 ­ 17, 1988.
7. DUESBERG, P. H. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc. Natl. Acad. Sci. USA 86:755 ­ 764, 1989.
8. KOVACS, J. A., and MASUR, H. Treatment of opportunistic infections. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. J. BIGGAR, and M. MELBYE. Philadelphia: Saunders, 1984.
9. PETERMAN, T. A.; STONEBURNER, R. L.; ALLEN, J. R.; et al. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion­associated infections. JAMA 259:55­58, 1988.
10. BOVE, J. R. The risk of AIDS from transfusion: a current assessment. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, edited by A. E. FRIEDMAN­KlEN and L. J. LAUBENSTEIN. New York: Masson, 1984.
11. DODD, R. Y., and SANDIER, S. G. Transfusion­associated AIDS. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. J. BIGGAR, and M. MELSYE. Philadelphia: Saunders, 1984.
12. CENTERS FOR DISEASE CONTROL. Human T­lymphotropic virus type III lymphadenopathy­associated virus antibody testing at alternative sites. MMWR 35:284 ­ 287, 1986.
13. DARROW, W. W.; ECHENBERG, D. F.; JAFFE, H. W.; et al. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am. J. Public Heallh 77(4):479 ­ 483, 1987.
14. WITKIN, S. S., and SONNABEND, J. Immune responses to spermatozoa in homosexual men. Fertil. Steril 39:337­342, 1983.
15. MAVLIGIT, C,. M.; TALPAZ, M.; HSIA, F. T; et al. Chronic immune stimulation by sperm alloantigens: support for the hypothesis that spermatazoa induce immune dysregulation in homosexual males. JAMA 251(2):237241, 1984.
16. MATHUR, S.; COUST, J.­M.; WILLIAMSON, H. O.; et al. Cross­reactivity of sperm and T­lymphocyte antigens. Am. J. Reprod. Immunol. 1:113­118, 1981.
17. MARCUS, Z. H.; LUNENFELD, B.; WEISSENBERG, R.; and LEWIN, L. M. Immunosuppressant material in human seminal fluid: inhibition of blast transformation and NK activity by seminal fluid patients of a male infertility clinic. Gynecol. Obstet Invest. 23:54­59. 1987.
18. WILLIAMSON, J. D. Semen polyamines in AIDS pathogenesis. Nature 310:103, 1984.
19. NEWELL, G. R.; MANSELL, P. W. A.; SPITZ, M. R.; et al. Volatile nitrites: use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. Am.J. Med. 78:811 ­ 816, 1985.
20. LYNCH, D. W.; MOORMAN, W. J.; BURG, J. R.; et al. Subchronic inhalation toxicity of isobutyl nitrite in BALB/c mice. 1. Systemic toxicity. 11. Immunotoxicity studies. J. Toxicol. Environ. Health 15(6):823 ­ 833, 835­846, 1985.
21. LOTZOVA, E.; SAVARY, C. A.; HERSH, E. M.; et al. Depression of murine natural killer cell cytotoxicity by isobutyl nitrite. Cancer Immunol. Immunother. 17:130­134, 1984.
22. OSTERLOH, J., and OLSON, K. Toxicities of alkyl nitrites. Ann. Intern. Med. 104(5):727, 1986.
23. PIFER, L. L. W.; WANC, Y.­F.; CHIANG, T. M.; et al. Borderline immunode ficiency in male homosexuals: is life­style contributory? South Med. J. 80(6): 687­697, 1987.
24. TARNAWSKI, A., and BATKO, B. Antibiotics and immune processes. Lancet 1:674, 1973.
25. MONSTER, A. M.; LOADHOLDT, C. B.; LEARY, A. C.; and BARNES, M. A. The effect of antibiotics on cell­mediated immunity. Surgery 81:692­696, 1977.
26. ALLEN, J. 1.; KAY, N. E.; and McCLAIN, E. J. Severe zinc deficiency in humans: association with a reversible T­lymphocyte dysfunction. Ann. Intern. Med. 95: 154 ­ 157, 1981.
27. CHANDRA, R. K., and Au, B. Single nutrient deficiency and cell­mediated immune responses. 1. Zinc. Am. J. Clin. Nutr. 33:736­738, 1980.
28. CHESTERS, J. K., and WILL, M. Measurement of zinc fiux through plasma in normal and endotoxin­stressed pigs and the effects of Zn supplementation during stress. Br.J. Nutr. 46:119 ­ 130, 1981.
29. DWORKIN, B. M., et al. Selenium deficiency in the acquired immunodeficiency syndrome. J. Parenter. Nutr. 10(4):405 ­ 407, 1986.
30. BRAMBILLA, G. Genotoxic effects of drug­nitrite interaction products: evidence for the need of risk assessment. Pharmacol. Res. Commun. 17(A):307321, 1985.
31. OSTERLOH, J.; et al. Butyl nitrite transformation in vitro, chemical nitrosation reactions, and mutagenesis. J. Anal. Toxicol. 8(4):164­169, 1984.
32. HAVERKOS, H. W.; PINSKY, P. F.; DROTMAN, D. P.; and BREGMAN, D. J. Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi's sarcoma. Sex. Transm. Dis. 12:203 ­ 208, 1985.
33. HAVERKOS, H. W., and DOUGHERTY, J. A. (eds.). Health Hazards of Nitrite Inhalants. National Institute on Drug Abuse (Monogr. 83), Washington, D.C., 1988.
34. LANGE, W. R., HAERTZEN, C. A.; MICKEY, J. E., et al. Nitrite inhalants: patterns of abuse in Baltimore and Washington, D.C. Am. J. Drug Akohol Abuse 14(1):29­40, 1988.
35. BOVI, P. D.; DONTI, E.; KNOWLES, D. M.; et al. Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS­associated Kaposi's sarcoma. Cancer Res. 46:6333­6338, 1986.
36. JUNKER, A. K., OCHS, H. D.; CLARK, E. A., et al. Transient immune deficiency in patients with acute Epstein­Barr virus infection. Clin. Immunol. Immunopathol. 40(3):436­446, 1986.
37. CARNEY, W. P.; RUBIN, R. H.; HORRMAN, R. A.; et al. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J. Immunol. 126(6):21142116, 1981.
38. MCCHESNEY, M. B.; et al. Viruses perturb Iymphocyte functions: selected principles characterizing virus­induced immunosuppression. Ann. Rev. Immunol. 5:279 ­ 304, 1987.
39. ROUSE, B. T., and HOROHOV, D. W. Immunosuppression in viral infections. Rev. Infect. Dis. 6:850­873, 1986.
40. LUSSO, P., ENSOLT, B; MARKHAM, P. D., et al. Productive dual infection of human CD4 + T Iymphocytes by HIV­I and HHV­6. Nature 7:370­373, 1989.
41. COREY, L. C., and HOLMES, K. K. Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N. Engl. J. Med. 302:435, 1980.
42. DIETZMAN, D. E.; HARNISCH, J. P.; RAY, C. G.; et al. Hepatitis B surface antigen (HBsAg) and antibody to HBsAg: prevalence in homosexual and heterosexual males. JAMA 238:2625, 1977.
43. DREW, W. L.; MINTZ, L.; MINER, R. C.; et al. Prevalence of cytomegalovirus infection in homosexual men. J. Infect. Dis. 143:188­192, 1981.
44. MARTINI, G. A.; et al. Inhibited Iymphocyte response to phytohemagglutinin (PHA) in acute infectious hepatitis and in chronic aggressive hepatitis: indirect evidence for virus persistence in chronic aggressive hepatitis? Scand. J. Gastroenterol. 7, suppl.: 39 ­ 42, 1970.
45. MELLA, B., and LANG, D. J. Leucocyte mitosis: suppression in vitro associated with acute infectious hepatitis. Science 155:80­81, 1967.
46. COULTER, H. L. AIDS and Syphilis: The Hidden Link. Berkeley, Calif. North Atlantic Books, 1987.
47. WORLD HEALTH ORGANIZATION. Consensus statements on HIV transmission. Lancet 1:396, 1989.
48. KAZAL, H. L.; SOHN, N.; CARRUSCO, J. L.; et al. The gay bowel syndrome: clinicopathological correlation in 260 cases. Ann. Clin. Lab. Sci. 6:184­192, 1976.
49. SCHMERIN, M. J; CELSTON, A.; and JONES, T. C. Amebiasis: an increasing problem among homosexuals in New York City. JAMA 238:1386, 1977.
50. MILLER, B.; STANSFIELD, S. K.; ZACK, M. M.; et al. The syndrome of unexplained generalized Iymphadenopathy in young men in New York City. JAMA 251(2):242 ­ 246, 1984.
51. BROWN, S. M.; STIMMEL, B.; TAUB, R. N.; et al. Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 134:1001­1006, 1974.
52. HARRIS, P. D., and GARRET, R. Susceptibility of addicts to infection and neoplasia. N. Engl. J. Med. 287(6):310, 1972.
53. SMOLAR, E. N.; PRYIMA, P. J.; and BERGER, S. Cytomegalovirus infection in a heroin addict. N.Y. State J. Med. 75(3):406, 1975.
54. FIROOZNIA, H.; SELIGER, C.; ABRAMS, R. M.; et al. Disseminated extrapulmonary tuberculosis in association with heroin addiction. Radiology 109:291­296, 1973.
55. SHAVIT, Y.; DEPAULIS, A.; MARTIN, F. C.; et al. Involvement of brain opiate receptors in the immune­suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83:7114­7117, 1986.
56. WEBER, R. J., and PERT, A. The periaqueductal gray matter mediates opiate­induced immunosuppression. Science 245:188­190, 1989.
57. WYBRAN, J.; APPELBOOM, T.; FAMAEY, J.­P.; and GOVAERTS, A. Suggestive evidence for receptors for morphine and methionine­enkephalin on normal human blood T Iymphocytes. J. Immunol. 123(1):1068­1070, 1979.
58. FALEK, A.; MADEN, J. J.; SHAFER, D. A.; and DONAHOE, R. M. Individual differences in opiate­induced alterations at the cytogenetic, DNA repair, and immunologic levels: opportunity for genetic assessment. Natl. Inst. Drug Abuse Res. Monogr. Ser. 66: 11 ­ 24, 1986.
59. DONAHOE, R. M.; NICHOLSON, J. K.; MADDEN, J. J.; et al. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T­cell Erosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 41(2):254­264, 1986.
60. DONAHOE, R. M.; BUESO­RAMOS, C.; DONAHOE, F.; et al. Mechanistic implications of the findings that opiates and other drugs of abuse moderate Tcell surface receptors and antigenic markers. Ann. N.Y. Acad. Sci. 496:711721, 1987.
61. KERMAN, R. H.; FLOYD, M.; VAN BUREN, C. T., and KAHAN, B. D. Improved allograft survival of strong immune responder­high risk recipients with adjuvant antithymocyte globulin therapy. Transplantation 30:450­454,
62. GOTTLIEB, M. S. AIDS in clinical practice. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. BIGCAR, and M. MELBYE. Philadelphia. Saunders, 1984.
63. SCOTT, F. I. AIDS and HIV: questions remain. Am. Lab. 21:4, 1989.
64. OSTREA, E. M., and CHAVEZ, C. J. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J. Pediatr. 94:292­295, 1979.
65. CHANDRA, R. K. Malnutrition. In Primary and Secondary Immunodeficiency Disorders, edited by R. K. CHANDRA. Edinburgh: Churchill Livingston,
66. DOWD, P. S., and HEATLEY, R. V. The influence of undernutrition on immunity. Clin. Sci. 66:241­248, 1984.
67. BURKE, R. A., and GOOD, R. A. Pneumocystis carinii infection. Medicine 52:23­51, 1973.
68. HUGHES, W. T.; PRICE, R. A.; SISKO, F.; et al. Protein­calorie malnutrition: a host determinant for Pneumocystis carinii infection. Am. J. Dis. Child. 128:44­52, 1974.
69. BOYNE, R.; ARTHUR, J. R.; and WILSON, A. B. An in vivo and in vitro study of selenium deficiency and infection in rats. J. Comp. Pathol. 96:379­386, 1986.
70. BOYNE, R., and ARTHUR, J. R. The response of selenium­deficient mice to Candida albicans infection. J.Nutr. 116:816 ­ 822, 1986.
71. REFFETT, J. K.; SPEARS, J. W.; and BROWN, T. T. Effect of dietary selenium on the primary and secondary immune response in calves challenged with infectious bovine rhinotracheitis virus. J. Nutr. 118:229­234, 1988.
72. MITCHISON, N. A. Induction of immunological paralysis in two zones of dosage. Proc. R. Soc. Lond. 161:275 ­ 292, 1964 ­ 1965.
73. SHEARER, C. M. Immune suppression and recognition of class II (la) antigens: a possible factor in the etiology of acquired immune deficiency syndrome. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, edited by A. E. FRIEDMAN­KIEN and L. J. LAUBENSTEIN. New York: Masson, 1984.
74. MACPHERSON, B. R.; et al. Alloimmunization to public HLA antigens in multi­transfused platelet recipients. Ann. Clin. Lab. Sci. 16(1):38­44, 1986.
75. FORWELL, M. A.; et al. Transfusion­induced, Fc gamma­receptor­blocking antibodies: spectrum of cellular reactivity. J. Clin. Lab. Sci. 20(2):63­67, 1986.
76. LEDERMAN, M. M.; RATNOFF, O. D.; SCILLIAN, J. J., et al. Impaired cellmediated immunity in patients with classic hemophilia. N. Engl. J. Med. 308:79, 1983.
77. KESSLER, C. M. K.; SHULOF, R. S.; GOLDSTEIN, A.; et al. Abnormal T Iymphocyte subpopulations associated with transfusions of blood­derived products. Lancet 1:991, 1983.
78. RICKARD, K. A.; et al. Absence of AIDS in haemophiliacs in Australia treated from an entirely voluntary blood donor system. Lancet 2:50­51, 1983.
79. FISCHER, E.; LENHARD, V.; SEIFERT, P.; et al. Blood transfusion-induced suppression of cellular immunity in man. Hum. Immunol. 3: 187­194, 1980.
80. JACOBS, R. F. Frozen deglycerolized blood and transmission of EpsteinBarr virus. J. Infect. Dis. 153(4) :800, 1986.
81. KAARIAINEN, L.; KLEMOLA, E.; and PALOHEIMO, J. Rise of cytomegalovirus antibodies in an infectious­mononucleosis­like syndrome after transfusion. Br. Med. J. 1:1270 ­ 1272, 1966.
82. GASCON, P.; ZUOMBOS, N. C.; and YOUNG, N. S. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann. Intern. Med. 100(2): 173­177, 1984.
83. KAPLAN, J.; SARNAIK, S.; CITLIN, J.; and LUSHER, J. Diminished helper/ suppressor Iymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308­310, 1984.
84. WAYMACK, J. P.; ROBB, E.; and ALEXANDER, J. W. Effect of transfusion on immune function in a traumatized animal model. Arch. Surg. 122:935939, 1987.
85. SALVATEIRRA, O.; VINCENT, T.; AMEND, W.; et al. Deliberate donor­specific blood transfusions prior to living related renal transplantation: a new approach. Ann. Surg. 192:543­552, 1980.
86. THOMAS, F. T.; CRAVER, F. M.; FOIL, M. B.; et al. Long­term incompatible kidney survival in outbred higher primates without chronic immunosuppression. Ann. Surg. 198:370­378, 1983.
87. FRANCIS, D. M. A., and SHENTON, B. K. Blood transfusion and tumour growth: evidence from laboratory animals. Lancet 2:871, 1981.
88. BURROWS, L., and TARTTER, P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet 2:662, 1982.
89. LENHARD, V.; MAASSEN, G.; GROSSE­WILDE, H.; et al. Effect of blood transfusions on immunoregulatory mononuclear cells in prospective transplant recipients. Transplant Proc. 15: 1011 ­ 1015. 1983.
90. DODD, R. Y., and SANDIER, S. G. Transfusion­associated AIDS. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. J. BIGGAR, and M. MELSYE. Philadelphia: Saunders, 1984.
91. WARD, J. W.; BUSH, T. J., PERKINS, H. A., et al. The natural history of transfusion­associated infection with human immunodeficiency virus. N. Engl. J. Med. 321 :947­968, 1989.
92. MORGAN, J.; et al. Persistent lymphadenopathy associated with hypertransfusion in sickle­cell disease. J. Allergy Clin. Immunol. 76:869­875, 1985.
93. HOWARD, R. J., and SIMMONS, R. L. Acquired immunologic deficiencies after trauma and surgical procedures. Surg. Gynecol. Obstet. 139:771­782,
94. SLADE, M. S.; SIMMONS, R. L.; YUNIS, E.; and GREENBERG, L. J. Immunodepression after major surgery in normal patients. Surgery 78:363372, 1975.
95. BOGART, L.; BONSIGNORE, J.; and CARVALHO, A. Massive hemolysis following inhalation of volatile nitrites. Am.J. Hematol. 22:327­329, 1986.
96. SOHN, N.; WEINSTEIN, M. A.; and GONCHAR, J. Social injuries of the rectum. Am.J. Surg. 134:611 ­ 612, 1977.
97. TSUDA, T., and KAHAN, B. D. The effects of anesthesia on the immune response. In Primary and Secondary Immunodefciency Disorders, edited by R. K. CHANDRA. Edinburgh: (,hurchill Livingston, 1983.
98. WINCARD, D. W.; LANG, R.; and HUMPHREY, L. J. Effect of anesthesia on immunity. J. Surg. Res. 7:430, 1967.
99. WARD, R. Mainstream scientists confront unorthodox view of AIDS. Nature 332:574, 1988.
100. SCOTT, G. B.; FISCHL, M. A.; KLIMAS, N.; et al. Mothers of infants with acquired immunodeficiency syndrome. JAMA 253:363­366, 1985.
101. PAWHA, S.; KAPLAN, M.; FIKRIG, S.; et al. Spectrum of human T­cell Iymphotropic virus type 111 infection in children. JAMA 255:2299­2305, 198fi.
102. MINKOFF, H.; NANDA, D.: MENEZ, R.; FIKRIG, S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AlDS­related complex: follow­up of mothers, children, and subsequently born siblings. Obstel. Gynecol. 69:288­291,1987.
103. CENTERS FOR DISEASE CONTROL. Update: acquired immunodeficiency Syndrome ­ United States, 1981­1988. MMWR 38(14):229­236,1989.
104. SHANNON, K. M., and AMMANN, A. J. Acquired immune deficiency syndrome in childhood. J. Pediatr. 106:332­342,1985.
105. FRICKER, H. S., and SECAL, S. Narcotic addiction, pregnancy, and the newborn. Am.J. Dis. Child. 132:360­366,1978.
106. VARCAS, C. C.; PILDES, R. S.; VIDYASACAR, D.; and KEITH, L. G. Effect of maternal heroin addiction on 67 liveborn neonates. Clin. Pediatr. 14:751757,1975.
107. OSTREA, E. M., and CIHAVEZ, Cl. J. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J. Pediatr. 94:292­295,1979.
108. ROMERO, R.; OYARZUN, E.; and MAZOR, M. Mechanisms at work when infection triggers preterm labor. Contemp. Ob/Gyn. 29:133­150,1989.
109. MILLER, H. C., and HASSANEIN, K. Fetal malnutrition in white newborn infants: maternal factors. Pediatrics 52:504­512,1973.
110. NAEYE, R. L.; BLANC, W.; and CHERYL, P. Eftects of maternal nutrition on the human fetus. Pediatrics 52:494­503,1973.
111. HAYNES, D. C.; COLUB, M. S.; GERSHWIN, M. E.; et al. Long­term marginal zinc deprivation in rhesus monkeys. II. Effects on maternal health and fetal growth at midgestation. Am.J. Clin. Nutr. 45:1503­1513,1987.
112. MULHERN, S. A.; TAYLOR, G. L.; MAGRUDER, L. E.; and VESSEY, A. R. Deficient levels of dietary selenium suppress the antibody response in first and second generation mice. Nutr. Res. 5:201­210, 1985.
113. ATKINSON, S. A.; WHELAN, D.; WHYTE, R. K.; and LONNERDAL, B. Abnormal zinc content in human milk. Am. J. Dis. Child. 143:608­611,1979.
114. NADAL, D.; HUNZIKER, U. A.; SHUPBACH, J.; et al. Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infection. Arch. Dis. Child. 64:662­669, 1989.
115. RUBIN, H. Etiology of AIDS. Science 241:1389­1390, 1988.
116. CENTERS FOR DISEASE CONTROL.. Recommendations for prevention of HIV transmission in health­care settings. MMWR 36, suppl.2S: 1S­5S, 1987.
117. CENTERS FOR DISEASE CONTROL. Occupationally acquired human immunodeficiency virus infections in laboratories producing virus concentrates in large quantities. MMWR 37(S­4):19­22, 1988.
118. STEWART, C. J.; TYLER, J. P. P.; CUNNINGHAM, A. L.; et al. 1 transmission of human T­cell lymphotropic virus type III (HTLV­III) hy artificial insemination by donor. Lancet 2:581­583,1985.
119. AKKER, S. VAN DEN, and GOEDBLOED, F. Pneumonia caused by PneumocNsli.s carinii in a dog. Trop. Geogr. Med. 12:54 ­ 58,1960.
120. CHOISSER, R. M., and RAMSEY, E. M. Etiology of Kaposi's disease. South. Med. J. 33(4):392 ­ 396,1940.
121. MEDEARIS, D. N., JR. Mouse cytomegalovirus infection. II. Observations during prolonged infections. Am. J. Hyg. 80:103­112,1964.
122. SHELDON, W. H. Experimental pulmonary Pneumocystis carinii infection in rabbits. J. Exp. Med. 110:147,1959.
123. NlCHOLS, P. W. Opportunistic int'ections and Kaposi's sarcoma in homosexual men. N. Engl. J. Med. 306(15):934 ­ 935,1982.
124. WILLIAMS, C.; STRETTON, T. B.; and LEONARD, J. C. Cytomegalic inclusion disease and Pneumocystis carinii infection in an adult. Lancet 2:951­955, 1960.
125. GRIFFIN, B. E. Burden of proof. Nature 338:670, 1989.
126. ROOT­BERNSTEIN, R. S. Discovering. Cambridge, Mass.: Harvard Univ. Press, 1989.
127. ROOT­BERNSTEIN, R. S. Setting the stage for discovery. The Sciences, pp. 26- 34, May/June 1988.
128. ROOT­BERNSTEIN, R. S. How scientists really think. Perspect. Biol. Med. 32:472­488, 1989.
129. JONAS, S. AIDS: an alternative scenario. Congressional Record, September 15, 1988.
130. SONNABEND, J. A. AIDS: an explanation for its occurrence among homosexual men. In AIDS and Opportunistic Infections of Homosexual Men, edited by P. MA and D. ARMSTRONG. Stoneham, Mass.: Butterworth, 1989.


vedi anche: altra Bibliografia + HIV = AIDS ? NO !

- Eleni Papadopulos Eleopulos et al., 'Mother to Child Transmission of HIV and its Prevention with AZT and Nevirapine'
- Marvin Kitzerow, 'The AIDS Indictment'

- Mohammed Al-Bayati, 'Get all The Facts: HIV does not cause AIDS'

- Joan Shenton, 'Positively False; Exposing the myths around HIV and AIDS'

- Roberto Giraldo, 'AIDS and Stressors'

- Steven Epstein, 'Impure Science; AIDS, activism, and the politics of knowledge'

- Neville Hodgkinson, 'AIDS: The failure of contemporary science'

- Peter Duesberg, 'Inventing the AIDS Virus'

- Peter Duesberg (virologist), 'AIDS; Virus or drug induced?'

- Peter Duesberg, 'Infectious AIDS: Have we been misled?'

- Ian Young, 'The Stonewall Experiment; A gay psychohistory'

- Ellinor Burkett, 'The Gravest Show on Earth; America in the age of AIDS'

- Robert Willner, 'Deathly Deception'

- Robert Root-Bernstein, 'Rethinking AIDS; The tragic cost of premature consensus'

- John Lauritsen & Ian Young (editors), 'The AIDS Cult: Essays on the gay health crisis'
- John Lauritsen, 'The AIDS War; Propaganda, profiteering and genocide from the medical-industrial complex'

- John Lauritsen, 'Poison by Prescription; The AZT story'

- Bruce Nussbaum, 'Good Intentions; How big business and the medical establishment are corrupting the fight against AIDS'

- Jad Adams, 'AIDS; The HIV myth'

- Jon Rappoport, 'AIDS Inc.; Scandal of the century'

Most recent releases are at left of the shelf, or top of the list.

"Il paziente malato di Aids NON muore a causa del virus dell'HIV ma per alterazioni dell'assorbimento intestinale  e quindi per ipoalimentazione  (malNutrizione), dovuta a una grave micosi." (By Dott. Gerhard Orth, Leuthkirch)
vedi: Aids its the Bacteria stupid - PDF + Aids its really caused by a virus ?

 

HOME

BACK